Oh Sang Kwon

3PUBLICATIONS
35CO-AUTHORS
Pharmaceutical delivery technologiesPredictive and prognostic markersRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 22, 2022
A Multi-Center, Double-Blind Randomized Controlled Phase III Clinical Trial to Evaluate the Antiviral Activity and Safety of DA-2802 (Tenofovir Disoproxil Orotate) and Viread (Tenofovir Disoproxil Fumarate) in Chronic Hepatitis B Patients.

Hyung Joon Kim, Ju Hyun Kim, Jong Eun Yeon

|Oct 29, 2020
Partial Virological Response after 2 Years of Entecavir Therapy Increases the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virus-Associated Cirrhosis.

Seung Kak Shin, Hyung Joon Yim, Jeong Han Kim

|Oct 26, 2019
Durability of Sustained Virologic Response and Improvement of Fibrosis Markers after Daclatasvir and Asunaprevir Treatment in Genotype 1b Hepatitis C Virus-Infected Patients: a Real Life and Multicenter Study.

Seung Kak Shin, Jin Woo Lee, Hannah Ra

Pageof 1

Frequent Collaborators

3 joint publications

Ju Hyun Kim

2 joint publications

Seung Kak Shin

2 joint publications

Jin-Woo Lee

2 joint publications

Jong Eun Yeon